Related Experiment Video
Updated: Jul 7, 2026
09:33
Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Cytochromes P450: a structure-based summary of biotransformations using representative substrates
Caitlin M Brown1, Brad Reisfeld, Arthur N Mayeno
1Quantitative and Computational Toxicology Group, Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado, USA.
Drug Metabolism Reviews
|February 9, 2008
Summary
This review outlines how Cytochromes P450 (CYPs) enzymes transform diverse chemicals, including drugs and toxicants. Visual data aids researchers in understanding xenobiotic metabolism and identifying key enzyme interactions.
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology and Toxicology
- Drug Metabolism and Pharmacokinetics (DMPK)
Background:
- Cytochromes P450 (CYPs) are critical enzymes responsible for metabolizing most foreign compounds (xenobiotics) in the human body.
- Understanding CYP-mediated biotransformations is essential for drug development, risk assessment of toxicants, and personalized medicine.
Purpose of the Study:
- To provide a structure-based overview of CYP-catalyzed biotransformations for a variety of xenobiotic substrates.
- To visually represent substrate structures and their sites of metabolic attack by major CYP isozymes.
- To compile key information on metabolites, responsible isozymes, and chemical classifications for selected xenobiotics.
Main Methods:
- Comprehensive literature review focusing on CYP-mediated metabolism of diverse xenobiotics.
- Structure-based analysis of substrate chemical structures and their known metabolic pathways.
- Tabular and visual (diagrammatic) presentation of biotransformation data, including sites of metabolism.
- Discussion of proposed pharmacophores for major CYP isozymes.
Main Results:
- Detailed data on CYP-catalyzed biotransformations of selected drugs and toxicants are presented in an easily accessible tabular format.
- Visual aids clearly illustrate substrate molecules and the specific positions undergoing metabolic modification.
- Information on major metabolites, the specific CYP isozymes involved, and the chemical class of each substrate is provided.
Conclusions:
- The presented visual and tabular compilation serves as a valuable reference for researchers studying xenobiotic metabolism.
- Understanding the structure-activity relationships and isozyme specificities of CYP biotransformations is crucial for predicting metabolic outcomes.
- This resource can aid in drug design, toxicity prediction, and the interpretation of drug-drug interactions mediated by CYPs.
More Related Videos
10:44Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
07:38A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
Related Concept Videos
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:28Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
01:19Phase I Oxidative Reactions: Overview
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...